Notice:
|
Suspension of shipments during Golden Week Holidays: From 30 April to 14 May, deadline 17 April.
|
|
NIG-RNAi Strains Detail |
Request : Click the "Order" button to request for this stock |
|
Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
Stock ID |
10390R-2 |
Symbol |
mia |
Full Name |
meiosis I arrest |
CG No |
CG10390 |
Old CG No |
CG10390 |
Synonyms |
dTAF6L, dTAF[[II]]60, dmTAF6b, Taf6L, TAF, TFIID, Taf60-2, dTAF[[II]]60-2, TAF[[II]], TAF6L, CG10390, TAF60-2, ms(3)570, mia |
Accession No (Link to NCBI) |
NM_141290.3 |
Inserted Chr. |
lll |
Insertional Mutation |
|
Phenotype induced by Act5C-GAL4 at 28 degrees |
viable |
Map Viewer |
|
Reference
[Please submit your publication]
|
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K. A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction. PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
|
Comment |
|
Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
Primer Seq. 5' |
aaggcctacatggccggaccgGTCTCAGAATGAAATGCCCGA |
Primer Seq. 3' |
aatctagaggtaccGATAGCGCTTGCTGGGCTTTA |
Predicted Fragment Size |
500 |
IR fragment full Seq |
0001 GTCTCAGAAT GAAATGCCCG ACAAGGACAA AAGTTTTCGC AGACATTCTT TGTCGCCGCG
0061 TTCTCTATCC GCGATATTCT TCCACAGCAC TGGTCTGCAT CTGGACGACG GAGTAGCACA
0121 GTGGCTATCC ATCAATGTTA AGGAAGACAT TACAAATCTG CTAAACGAGG CTGGAAAATA
0181 NCATGCGGCG CATCCGGGAT CGGCGATTGC AACTGTCTCA CATCCAGCAT GCCGTCCGAA
0241 TGCACGACGA CCTCTGCTAT GACATCTTTT TTAGGCTGGT CCATTGCGAC GATTGCAAAA
0301 TGCCTCCTTC CCAAAAAGTA TTAAAAACCG TCCGCGAAGC TGNTAACCGC CGAAAAAAAG
0361 GATGAACTTC TCGTTTCCTA CCCGGAATCC GTGCAGGAAT CTGTGCCGGA ACCCGTGCCG
0421 GAGACTTCAT TGGAGCCGCC TCCCATGCAC ACCGGGTGGC TAAAGGTGGA GCAGGTGCTG
0481 CTAAAGCCCA GCAAGCGCTA TC |
in silico PCR Fragment |
0001 GTCTCAGAAT GAAATGCCCG ACAAGGACAA AAGTTTTCGC AGACATTCTT TGTCGCCGCG
0061 TTCTCTATCC GCGATATTCT TCCACAGCAC TGGTCTGCAT CTGGACGACG GAGTAGCACA
0121 GTGGCTATCC ATCAATGTTA AGGAAGACAT TACAAATCTG CTAAACGAGG CTGGAAAATA
0181 -CATGCGGCG CATCCGGGAT CGGCGATTGC AACTGTCTCA CATCCAGCAT GCCGTCCGAA
0241 TGCACGACGA CCTCTGCTAT GACATCTTTT TTAGGCTGGT CCATTGCGAC GATTGCAAAA
0301 TGCCTCCTTC CCAAAAAGTA TTAAAAACCG TCCGCGAAGC TG-TAACCGC CGAAAAAAAG
0361 GATGAACTTC TCGTTTCCTA CCCGGAATCC GTGCAGGAAT CTGTGCCGGA ACCCGTGCCG
0421 GAGACTTCAT TGGAGCCGCC TCCCATGCAC ACCGGGTGGC TAAAGGTGGA GCAGGTGCTG
0481 CTAAAGCCCA GCAAGCGCTA TC |
Assemble Data |
10390R-2.IR_full 1 GTCTCAGAATGAAATGCCCGACAAGGACAAAAGTTTTCGCAGACATTCTTTGTCGCCGCG 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10390R-2.in silico 1 GTCTCAGAATGAAATGCCCGACAAGGACAAAAGTTTTCGCAGACATTCTTTGTCGCCGCG 60
10390R-2.IR_full 61 TTCTCTATCCGCGATATTCTTCCACAGCACTGGTCTGCATCTGGACGACGGAGTAGCACA 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10390R-2.in silico 61 TTCTCTATCCGCGATATTCTTCCACAGCACTGGTCTGCATCTGGACGACGGAGTAGCACA 120
10390R-2.IR_full 121 GTGGCTATCCATCAATGTTAAGGAAGACATTACAAATCTGCTAAACGAGGCTGGAAAATA 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10390R-2.in silico 121 GTGGCTATCCATCAATGTTAAGGAAGACATTACAAATCTGCTAAACGAGGCTGGAAAATA 180
10390R-2.IR_full 181 CATGCGGCGCATCCGGGATCGGCGATTGCAACTGTCTCACATCCAGCATGCCGTCCGAA 239
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10390R-2.in silico 181 CATGCGGCGCATCCGGGATCGGCGATTGCAACTGTCTCACATCCAGCATGCCGTCCGAA 239
10390R-2.IR_full 241 TGCACGACGACCTCTGCTATGACATCTTTTTTAGGCTGGTCCATTGCGACGATTGCAAAA 299
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10390R-2.in silico 241 TGCACGACGACCTCTGCTATGACATCTTTTTTAGGCTGGTCCATTGCGACGATTGCAAAA 299
10390R-2.IR_full 301 TGCCTCCTTCCCAAAAAGTATTAAAAACCGTCCGCGAAGCTGNTAACCGCCGAAAAAAAG 359
|||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||
10390R-2.in silico 301 TGCCTCCTTCCCAAAAAGTATTAAAAACCGTCCGCGAAGCTG-TAACCGCCGAAAAAAAG 359
10390R-2.IR_full 361 GATGAACTTCTCGTTTCCTACCCGGAATCCGTGCAGGAATCTGTGCCGGAACCCGTGCCG 419
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10390R-2.in silico 361 GATGAACTTCTCGTTTCCTACCCGGAATCCGTGCAGGAATCTGTGCCGGAACCCGTGCCG 419
10390R-2.IR_full 421 GAGACTTCATTGGAGCCGCCTCCCATGCACACCGGGTGGCTAAAGGTGGAGCAGGTGCTG 479
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10390R-2.in silico 421 GAGACTTCATTGGAGCCGCCTCCCATGCACACCGGGTGGCTAAAGGTGGAGCAGGTGCTG 479
10390R-2.IR_full 481 CTAAAGCCCAGCAAGCGCTATC 501
||||||||||||||||||||||
10390R-2.in silico 481 CTAAAGCCCAGCAAGCGCTATC 501
|
Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
4 |
NM_141290.3 |
CG10390-RA (mia), mRNA |
0 |
0 |
2 |
5 |
7 |
NM_134600.1 |
CG1494-RA (CG1494), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_057425.2 |
CG9450-RA (tud), mRNA |
0 |
0 |
1 |
3 |
6 |
NM_167570.1 |
CG8465-RC, transcript variant C (l(1)G0222), mRNA |
0 |
0 |
1 |
3 |
6 |
NM_167569.1 |
CG8465-RB, transcript variant B (l(1)G0222), mRNA |
0 |
0 |
1 |
3 |
6 |
NM_132993.2 |
CG8465-RA, transcript variant A (l(1)G0222), mRNA |
0 |
0 |
1 |
3 |
3 |
NM_134486.1 |
CG14221-RA (CG14221), mRNA |
0 |
0 |
1 |
3 |
2 |
NM_169668.1 |
CG31461-RA (CG31461), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_206628.1 |
CG32767-RB, transcript variant B (CG32767), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_131975.3 |
CG32767-RA, transcript variant A (CG32767), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_132852.1 |
CG8565-RA (CG8565), mRNA |
0 |
0 |
1 |
2 |
6 |
NM_137081.2 |
CG30483-RA (Prosap), mRNA |
0 |
0 |
1 |
2 |
6 |
NM_167277.1 |
CG11105-RA, transcript variant A (CG11105), mRNA |
0 |
0 |
1 |
2 |
6 |
NM_132471.1 |
CG11105-RB, transcript variant B (CG11105), mRNA |
0 |
0 |
1 |
2 |
5 |
NM_132004.2 |
CG4136-RA (CG4136), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_080138.2 |
CG1618-RA (comt), mRNA |
0 |
0 |
0 |
7 |
2 |
NM_168822.2 |
CG8363-RB, transcript variant B (Paps), mRNA |
0 |
0 |
0 |
7 |
2 |
NM_168821.2 |
CG8363-RA, transcript variant A (Paps), mRNA |
0 |
0 |
0 |
7 |
2 |
NM_168823.2 |
CG8363-RC, transcript variant C (Paps), mRNA |
0 |
0 |
0 |
7 |
2 |
NM_079447.3 |
CG8363-RE, transcript variant E (Paps), mRNA |
0 |
0 |
0 |
7 |
2 |
NM_168824.2 |
CG8363-RD, transcript variant D (Paps), mRNA |
0 |
0 |
0 |
7 |
2 |
NM_001043152.1 |
CG8363-RF, transcript variant F (Paps), mRNA |
0 |
0 |
0 |
5 |
5 |
NM_142739.2 |
CG6678-RA (CG6678), mRNA |
0 |
0 |
0 |
5 |
3 |
NM_057882.3 |
CG1609-RA (Gcn2), mRNA |
0 |
0 |
0 |
5 |
3 |
NM_166293.1 |
CG17725-RB, transcript variant B (Pepck), mRNA |
0 |
0 |
0 |
5 |
3 |
NM_079060.2 |
CG17725-RA, transcript variant A (Pepck), mRNA |
0 |
0 |
0 |
5 |
2 |
NM_057526.3 |
CG5920-RA (sop), mRNA |
0 |
0 |
0 |
4 |
5 |
NM_142621.3 |
CG5077-RA, transcript variant A (CG5077), mRNA |
0 |
0 |
0 |
4 |
5 |
NM_169892.2 |
CG5077-RB, transcript variant B (CG5077), mRNA |
0 |
0 |
0 |
4 |
5 |
NM_169893.2 |
CG5077-RC, transcript variant C (CG5077), mRNA |
|
|
|